BDBM50582817 CHEMBL5076914

SMILES Brc1ccc(NC(=O)NC2CCN(C2=O)c2ccccc2)cc1

InChI Key InChIKey=KCNQCLLNZNTDNL-UHFFFAOYSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50582817   

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50582817(CHEMBL5076914)
Affinity DataEC50:  430nMAssay Description:Agonist activity at FPRL1 (unknown origin) expressed in CHO-K1 cells assessed as increase in calcium mobilization incubated for 2.5 hrs by cellular b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50582817(CHEMBL5076914)
Affinity DataEC50:  300nMAssay Description:Agonist activity at FPRL1 (unknown origin) expressed in CHO-K1 cells assessed as stimulation of beta-arrestin recruitment incubated for 150 mins by b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50582817(CHEMBL5076914)
Affinity DataEC50:  1.74E+3nMAssay Description:Agonist activity at human FPR1 expressed in HEK293-A cells assessed as ERK phosphorylation level incubated for 5 mins by ELISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50582817(CHEMBL5076914)
Affinity DataEC50:  7.36E+3nMAssay Description:Agonist activity at human FPR2 expressed in HEK293-A cells assessed as ERK phosphorylation level incubated for 5 mins by ELISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed